Skip to Content

Emgality

Licence status
Authorised: 14/11/2018
Active substances
GALCANEZUMAB
Dosage Form
Solution for injection
Licence number
EU/1/18/1330/001-004
Licence holder
Eli Lilly Nederland B.V.

Licence information

ATC code
N02CX08 galcanezumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
14/11/2018